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Background Little isknown aboutthe
epidemiologyof adult attention-deficit
hyperactivitydisorder (ADHD).
Aims To estimate the prevalence and
correlates of DSM^IVadult ADHDinthe
World Health OrganizationWorld Mental
Health Survey Initiative.
Method An ADHD screenwas
administered to respondents aged18^44
years inten countries inthe Americas,
Europe and the Middle East (n¼11422).
Masked clinicalreappraisal interviews
were administered to154 USrespondents
to calibratethe screen.Multipleimputation
wasused to estimate prevalence and
correlates based onthe assumption of
cross-national calibration comparability.
Results Estimates of ADHD
prevalence averaged 3.4% (range1.2^
7.3%), with lowerprevalence in lower-
income countries (1.9%) comparedwith
higher-income countries (4.2%).Adult
ADHDoften co-occurswith other
DSM^IVdisorders and is associatedwith
considerable role disability.Fewcases are
treated for ADHD, but inmanycases
treatment isgiven forcomorbid disorders.
Conclusions Adult ADHD should be
consideredmore seriously in future
epidemiological and clinical studies than is
currently the case.
Declaration of interest None.
Fundingdetailed in Acknowledgements.
It has long been known from clinical
follow-up studies that children with
attention-deficit hyperactivity disorder
(ADHD) often continue to have symptoms
in adulthood (Weiss & Hechtman, 1993),
that symptoms of inattention are more
likely to persist into adulthood than
symptoms of hyperactivity or impulsivity
(Wilens et al, 2004) and that adults with a
history of childhood ADHD have a com-
paratively high prevalence of other mental
disorders that develop subsequent to
ADHD and might be to some extent conse-
quences of primary ADHD (Biederman,
2004); however, adult ADHD has only
recently become the focus of widespread
clinical attention (Wilens et al, 2004). Not
only is the study of adult ADHD compara-
tively new, it is also characterised by
controversy due to lack of agreement on
appropriate diagnostic criteria and the
realisation that diagnosis is complicated
by symptom overlap with a number of
other disorders (McGough & Barkley,
2004).
As adult ADHD was not included in
any of the major psychiatric epidemio-
logical surveys that have been carried out
around the world since the landmark
Epidemiologic Catchment Area study in
the early 1980s (Weissman et al, 1996;
World Health Organization (WHO) Inter-
national Consortium in Psychiatric Epi-
demiology, 2000), attempts to estimate
adult ADHD prevalence have been based
either on extrapolations from childhood
prevalence estimates using information
from clinical studies regarding the propor-
tion of childhood cases that persist into
adulthood (Barkley et al, 2002) or on direct
estimates from small samples (Faraone &
Biederman, 2005). Most of the studies of
either type have taken place in the USA,
where estimates of adult ADHD prevalence
are in the range 1–6%. A review by Far-
aone et al (2003) based on 20 studies in
the USA and 30 studies in other countries
found that prevalence estimates of
childhood and adolescent ADHD were as
high in many non-US studies as in US
studies. Studies of adult ADHD in non-US
populations, though, are much rarer. The
only general-population non-US study took
place in a town in The Netherlands (Kooij
et al, 2005), but absence of information
on age of onset and pervasiveness of symp-
toms made it impossible to generate an un-
biased prevalence estimate of adult ADHD
in this population. In order to obtain more
accurate estimates of prevalence and corre-
lates of adult ADHD, a screen for this dis-
order was developed for use in the World
Health Organization World Mental Health
(WMH) surveys (Demyttenaere et al,
2004). We present here the results from
the ten WMH surveys that included this
screen.
METHOD
Samples
Adult ADHD was assessed in the following
WMH countries: Belgium, Colombia,
France, Germany, Italy, Lebanon, Mexico,
The Netherlands, Spain and the USA. Three
of these ten are classified by the World
Bank as ‘less developed’ (Colombia,
Lebanon and Mexico; World Bank, 2003).
The other seven countries are classified as
‘developed’. All surveys were conducted
face-to-face by trained lay interviewers in
multi-stage household probability samples
(Table 1). The weighted average response
rate across all ten of these countries was
67.9%, with a range of 45.9–87.7%.
The WMH interview schedule was in
two parts. All respondents completed
part I, which contained core diagnostic
assessments. All part I respondents who
met criteria for any of these core disorders
plus a probability subsample of other
part I respondents were administered
part II, which assessed disorders of second-
ary interest and a wide range of correlates.
Adult ADHD was assessed in part II. As
one requirement for a diagnosis of ADHD
is onset of symptoms in childhood, the
assessment was limited to respondents in
the age range 18–44 years because of con-
cerns about accuracy of retrospective recall
among older respondents. A total of 11 422
respondents in this age range were screened
across the ten surveys, with the size of
within-country samples ranging from
3197 in the USA to 486 in Belgium.
The WMH interview schedule and all
other study training materials and
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respondent visual aids were translated
using standardised World Health
Organization (WHO) translation and
back-translation protocols (these materials
are posted at http://www.hcp.med.harvard.
edu/wmh). Consistent interviewer training
and quality control procedures were used
in all surveys. Procedures for informed con-
sent, which was obtained in all countries
before beginning interviews, were approved
and monitored for compliance by the insti-
tutional review boards of the organisations
coordinating the surveys in each country.
Adult ADHD
The retrospective assessment of childhood
ADHD in the WMH surveys was based
on the Diagnostic Interview Schedule for
DSM–IV (DIS; Robins et al, 1995).
Respondents classified retrospectively as
having met full ADHD criteria in childhood
were then asked a single question about
whether they continued to have any current
problems with attention or hyperactivity–
impulsivity. A clinical reappraisal interview
of these respondents was carried out in a
probability subsample of 154 respondents
in the WMH sample in the USA using the
Adult ADHD Clinical Diagnostic Scale,
version 1.2 (ACDS; Adler & Cohen,
2004; Adler & Spencer, 2004), a semi-
structured interview which includes the
ADHD Rating Scale (ADHD–RS; DuPaul
et al, 1998) for childhood ADHD and an
adaptation of the ADHD–RS to assess
current adult ADHD. The ACDS has been
used in clinical trials of adult ADHD
(Spencer et al, 2001; Michelson et al, 2003).
Four experienced clinical interviewers
(all PhD-qualified clinical psychologists)
conducted the clinical reappraisal inter-
views. Each interviewer received 40 h of
training from two board-certified psychia-
trists, specialists in the treatment of adult
ADHD, and successfully completed five
practice interviews. All clinical interviews
were tape-recorded and reviewed by a
supervisor. Weekly calibrator meetings
were used to prevent drift. A clinical
diagnosis of adult ADHD required six
symptoms of either inattention or
hyperactivity–impulsivity during the 6
months before the interview (DSM–IV
criterion A; American Psychiatric Associa-
tion, 1994), at least two criterion A symp-
toms before age 7 years (criterion B),
some impairment in at least two areas of
living during the previous 6 months
(criterion C) and clinically significant
impairment in at least one of these
areas (criterion D). No attempt was
made to operationalise DSM–IV diagnostic
hierarchy rules (criterion E).
The DIS questions used to assess
ADHD in the main survey were treated as
independent variables in the subsample of
clinical reappraisal respondents who
reported recent symptoms to predict
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Table1 Sample characteristics
Country Survey Sample characteristics1 Field dates Adult ADHD
subsample
size2 n
Response
rate3
Belgium ESEMeD Stratifiedmultistage clustered probability sample of individuals residing in
households from the national register of Belgium residents (NR)
2001/2 486 50.6
Colombia NSMH Stratifiedmultistage clustered area probability sample of household residents in all
urban areas of the country (approximately 73% of the total national population)
2003 1731 87.7
France ESEMeD Stratifiedmultistage clustered sample ofworking telephonenumbersmergedwith a
reverse directory (for listed numbers); initial recruitment was by telephone, with
supplemental in-person recruitment in households with listed numbers (NR)
2001/2 727 45.9
Germany ESEMeD Stratifiedmultistage clustered probability sample of individuals from community
resident registries (NR)
2002/3 621 57.8
Italy ESEMeD Stratifiedmultistage clustered probability sample of individuals frommunicipality
resident registries (NR)
2001/2 853 71.3
Lebanon LEBANON Stratifiedmultistage clustered area probability sample of household residents (NR) 2002/3 595 70.0
Mexico M^NCS Stratifiedmultistage clustered area probability sample of household residents in all
urban areas of the country (approximately 75% of the total national population)
2001/2 1736 76.6
Netherlands ESEMeD Stratifiedmultistage clustered probability sample of individuals residing in
households that are listed in municipal postal registries (NR)
2002/3 516 56.4
Spain ESEMeD Stratifiedmultistage clustered area probability sample of household residents (NR) 2001/2 960 78.6
USA NCS^R Stratifiedmultistage clustered area probability sample of household residents (NR) 2002/3 3197 70.9
ADHD, attention-deficit hyperactivity disorder; ESEMeD, European Study of the Epidemiology of Mental Disorders; LEBANON, Lebanese Evaluation of the Burden of Ailments and
Needs of the Nation; M^NCS,Mexico National Comorbidity Survey; NCS^R,National Comorbidity Survey Replication; NR, nationally representative; NSMH,Colombian National
Study of Mental Health.
1. MostWorld Mental Health (WMH) surveys are based on stratifiedmultistage clustered area probability household samples inwhich samples of areas equivalent to counties in the
UKwere selected in the first stage followedby one ormore subsequent stages of geographic sampling (e.g. townswithin counties, blocks within towns, households within blocks) to
arrive at a sample of households, in each of which a listing of householdmemberswas created and one or two peoplewere selected from this listing to be interviewed.No substitution
was allowedwhen the originally sampled household resident could not be interviewed.These household samples were selected from census area data in all countries other than
France (where telephone directorieswere used to select households) and TheNetherlands (where postal registrieswere used to select households). SeveralWMH surveys (Belgium,
Germany, Italy) usedmunicipal resident registries to select respondents without listing households. Eight of the tenWMH surveys considered here are based on nationally represen-
tative household samples; the two others are based on nationally representative household samples in urban areas (Colombia,Mexico).
2. Attention-deficit hyperactivity disorder was assessed only among respondents in the age range18^44 years in the Part II sample of each survey.
3. Calculated as the proportion of the number of households in which an interview was completed to the number of households originally sampled, excluding from the denominator
households known not to be eligible either because of being vacant at the time of initial contact or because the residents were unable to speak the designated languages of the survey.
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masked clinician diagnoses of DSM–IV
adult ADHD. As detailed elsewhere
(Kessler et al, 2006), a strong association
(with an area under the receiver operating
characteristic curve of 0.86) was found be-
tween these independent variables and the
clinical diagnoses, based on a four-category
classification scheme that distinguished
respondents in terms of whether they
reported no childhood symptoms of
ADHD, sub-threshold symptoms, threshold
symptoms in the absence of adult per-
sistence or threshold symptoms with adult
persistence. This strong association between
the DIS questions and the masked clinical
diagnoses provided the empirical justifica-
tion for using the DIS symptom recency
questions to generate a predicted probabil-
ity of adult ADHD for every respondent
in the larger samples. It needs to be noted,
however, that a major limitation in this ap-
proach is that we have no way of knowing
from these data whether the same strong
association between the DIS and clinical
diagnoses holds in countries other than
the USA.
Co-occurring DSM^IVdisorders
Other DSM–IV disorders were assessed in
the WMH surveys using the WHO
Composite International Diagnostic Inter-
view, version 3.0 (CIDI; Kessler & Ustun,
2004), a fully structured, lay-administered
diagnostic interview. The core disorders in-
clude anxiety disorders, mood disorders
and substance use disorders. Organic exclu-
sion rules and diagnostic hierarchy rules
were used in making diagnoses. As detailed
elsewhere (Haro et al, 2007), masked
clinical reappraisal interviews using the
Structured Clinical Interview for DSM–IV
(SCID; First et al, 2002) with a probability
subsample of respondents from the US
survey found acceptable concordance of
DSM–IV diagnoses based on the CIDI and
SCID interviews in four WMH countries
where clinical reappraisal studies were
carried out. Each CIDI diagnostic section
included questions about age at onset of
the focal disorder. These retrospective re-
ports of age at onset were compared for
ADHD and other DSM–IV disorders
among respondents who met criteria for
adult ADHD with comorbid anxiety, mood
and substance use disorders in order to
study temporal priorities in these cases of
co-occurrence.
Other correlates of adult ADHD
We examined associations of adult ADHD
with socio-demographic data and role
disability, assessed with the WHO Dis-
ability Assessment Schedule (WHO–DAS;
Chwastiak & Von Korff, 2003). The
WHO–DAS assesses frequency and inten-
sity of restriction or lack of ability to per-
form activities in a number of domains
over the past 30 days. Three areas of basic
activity were considered – mobility (e.g.
walking a mile), self-care (e.g. getting
dressed) and cognition (e.g. remembering
to do important things) – along with two
areas of instrumental activity – ‘time out
of role’ (i.e. number of days totally unable
to carry out normal daily activities) and
social role performance (e.g. controlling
emotions when around other people).
Dichotomous measures of disability were
defined for the dimensions of mobility,
self-care, cognition and social role by giving
equal weights to frequency and intensity
and defining disability as having any diffi-
culty in basic functioning or role perfor-
mance. The dichotomy for time out of
role was defined as having more than 8 days
out of role.
We asked about treatment of specific
emotional and substance problems in sepa-
rate diagnostic sections of the CIDI. We
also asked a more general series of ques-
tions about seeking treatment for any
emotional problem in a separate treatment
section of the interview. Comparison of
responses about treatment of ADHD and
about treatment of emotional problems
more generally allowed us to pinpoint
people with ADHD who had received treat-
ment for comorbid mental or substance use
problems but not for ADHD.
Analysis methods
A prediction equation estimated in the clin-
ical reappraisal sample was used to gener-
ate a predicted probability of DSM–IV
adult ADHD for each respondent who
was administered the DIS ADHD section
in the main interview but who did not com-
plete a clinical reappraisal interview. The
method of multiple imputation (Rubin,
1987) was used to convert these predicted
probabilities into dichotomous diagnostic
classifications and to adjust significance
tests for the fact that the predicted clinical
diagnoses are imperfectly related to actual
clinical diagnoses. This method is based
on the assumption that the calibration of
the DIS ADHD symptom and recency
questions in the US clinical reappraisal
study applies equally well to the other
WMH countries – an assumption that
cannot be tested here in light of the fact that
no clinical reappraisal study for adult
ADHD was conducted in any of the other
countries.
Socio-demographic correlates were esti-
mated using multiple imputation logistic
regression analysis. Co-occurrence was
assessed by obtaining multiply imputed
estimates of odds ratios between adult
ADHD and other DSM–IV disorders in
logistic regression equations that controlled
for age in 5-year age groups. Functional dis-
abilities were also estimated using multiple
imputation logistic regression. Twelve-
month treatment was estimated using
multiple imputation cross-tabulations. In
each phase of analysis we generated esti-
mates both separately for each of the
ten samples and also in a combined cross-
sample analysis that included nine dummy
control variables to indicate country. Inter-
actions were then estimated between the
country dummies and the substantive
predictors to evaluate the significance of
between-country differences. Such differ-
ences, although few in number, are noted
in the following presentation of substantive
results.
Part I cases were weighted to adjust for
differential probabilities of selection within
and between households and to match
sample distributions to population distribu-
tions on socio-demographic and geographic
data. The part II sample was additionally
weighted for the undersampling of part I
respondents without core disorders.
Because the sample design used this weight-
ing as well as geographic clustering, all
parameters were estimated using the Taylor
series linearisation method (Wolter, 1985),
a design-based method implemented in the
SUDAAN software system (Research
Triangle Institute, North Carolina, USA).
All significance tests used two-sided Wald
w2 tests based on design-corrected multiple
imputation variance–covariance matrices.
RESULTS
Prevalence
The estimated prevalence of DSM–IV adult
ADHD in the total sample based on
multiple imputation, using a combination
of directly interviewed cases from the
clinical reappraisal sample in the USA and
multiply imputed cases in the remainder
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of the samples, was 3.4%, s.e.¼0.4 (Table
2). Prevalence estimates were significantly
higher than this average in France (7.3%,
s.e.¼1.8) and significantly lower in
Colombia (1.9%, s.e.¼0.5), Lebanon
(1.8%, s.e.¼0.7), Mexico (1.9%, s.e.¼0.4)
and Spain (1.2%, s.e.¼0.6).
Socio-demographic correlates
Multiple imputation prevalence estimates
of clinician-assessed adult ADHD were sig-
nificantly greater in the total cross-national
sample among men and among people edu-
cated to less than university level (Table 3),
but these effects were modest in magnitude
(1.55OR53.0). No significant between-
country difference was found in the magni-
tude of the effects of gender and education,
although it is noteworthy that there was
little power to detect such effects (further
details available from the authors).
Co-occurrence with other
DSM^IVdisorders
Adult ADHD was significantly associated
with a wide range of other 12-month
DSM–IV disorders (Table 4). The strength
of these associations in terms of odds ratios
was remarkably consistent across classes of
disorder, with OR¼3.9 (95% CI 3.0–5.1)
for mood disorders, OR¼4.0 (95% CI
3.0–5.2) for anxiety disorders and
OR¼4.0 (95% CI 2.8–5.8) for substance
use disorders. A dose–response relationship
exists between ADHD and number of other
disorders, with the highest odds ratio
(OR¼7.2, 95% CI 5.1–10.2) associated
with having three or more other disorders.
Within-country patterns were similar to
those in the combined sample, with a pre-
dominantly positive sign pattern (68 of
the 70 odds ratios in the ten separate coun-
tries were greater than 1.0) and 56% of the
within-country odds ratios significant at the
P50.05 level. However, this pattern was
notably weaker in France (further details
available from the authors).
Temporal priorities among
co-occurring disorders
Retrospective reports of age at onset were
used to compare temporal priority between
the first onset of ADHD and that of co-
occurring disorders among respondents
with adult ADHD (Table 5). The ADHD
was reported to have started at an earlier
age than the vast majority of co-occurring
mood disorders (85.6%), anxiety disorders
other than specific phobia (68.5%) and
substance use disorders (99.0%). However,
co-occurring specific phobia was reported
to start at an earlier age than ADHD more
often than the reverse (54.8% specific
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Table 2 Multiply imputed prevalence estimates of
adult attention-deficit hyperactivity disorder
Country Prevalence, % (s.e.) n
Belgium 4.1 (1.5) 486
Colombia 1.91 (0.5) 1731
France 7.32 (1.8) 727
Germany 3.1 (0.8) 621
Italy 2.8 (0.6) 853
Lebanon 1.81 (0.7) 595
Mexico 1.91 (0.4) 1736
Netherlands 5.0 (1.6) 516
Spain 1.21 (0.6) 960
USA3 5.2 (0.6) 3197
Total 3.4 (0.4) 11422
1. The upper end of the 95% confidence interval of this
estimate is below the prevalence estimate for the total
sample.
2. The lower end of the 95% confidence interval of this
estimate is above the prevalence estimate for the total
sample.
3. This estimate differs somewhat from an estimate
reported elsewhere (Kessler et al, 2006) because it is
based on a different imputation equation.The equation
used here is less complex because it had to be limited to
variables included in all the surveys.
Table 3 Socio-demographic correlates of adult attention-deficit hyperactivity disorder (n¼11422)
Correlates % (s.e.)2 OR (95% CI) w2 3
Gender
Male 4.1 (0.5) 1.5* (1.1^1.9)
Female 2.7 (0.3) 1.0 15.5*
Age, years
18^24 3.6 (0.5) 1.0 (0.6^1.5)
25^34 3.6 (0.5) 1.3* (1.0^1.7)
35^44 3.1 (0.4) 1.0 3.5
Education
Less than secondary 3.0 (0.4) 3.0* (2.0^4.6)
Secondary 5.1 (0.9) 3.0* (1.8^4.8)
Some post-secondary 3.5 (0.5) 2.3* (1.5^3.4)
University graduate 1.6 (0.3) 1.0 26.5*
Employment status
Employed 3.5 (0.4) 1.0 (0.7^1.7)
Student 2.2 (0.6) 0.9 (0.4^2.1)
Homemaker 1.9 (0.4) 1.0
Retired 7.8 (5.9) 2.3 (0.5^10.5)
Unemployed 5.5 (1.0) 1.5 (0.8^2.9) 0.7
Marital status
Married/cohabiting 3.0 (0.4) 1.0
Previously married 5.4 (1.0) 2.0 (0.9^4.4)
Never married 3.7 (0.5) 1.2 (0.9^1.6) 6.4*
Income4
Low 4.2 (0.6) 0.9 (0.6^1.4)
Low-average 3.2 (0.5) 0.8 (0.5^1.3)
High-average 3.2 (0.4) 0.8 (0.5^1.2)
High 3.0 (0.6) 1.0 0.1
1. Correlates of multiply imputed DSM^IVadult attention-deficit hyperactivity disorder (ADHD) in the pooled
surveys, based on a multivariate logistic regression equation in which all predictors were included simultaneously.
2. Percentages reported are the conditional prevalence estimates of ADHD in the socio-demographic subsamples.
3. The w2 tests all have one degree of freedom.Tests for age, education and income are based on continuous versions of
those predictors.The test for employment status compares employed v. all others.The test formarital status compares
married/cohabiting v. all others.
4. Income is defined as the ratio of pre-tax family income to number of householdmembers.Households with ratios
half themedian or lower were categorised as ‘low’ income; thosewith ratios between half themedian and themedian
were categorised as ‘low-average’; thosewith ratios greater than themedian up to three times themedian as ‘high-
average’; and those greater than three times themedian as ‘high’.
*P50.05, two-sided test.
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phobia first v. 34.3% ADHD first). These
patterns are very robust across countries
(further details available from the authors).
Disability
Adult ADHD was associated with signifi-
cantly elevated odds ratios of disability in
two of the three WHO–DAS dimensions
of basic functioning – mobility (OR¼2.2,
95% CI 1.6–2.9) and cognition (OR¼3.9,
95% CI 2.8–5.4) – but not in the third
dimension of self-care (OR¼1.5, 95% CI
0.8–2.8) (Table 6). Adult ADHD was also
associated with elevated risk of high num-
ber of days out of role (OR¼2.6, 95% CI
2.0–3.5) and with disability in social func-
tioning (OR¼3.1, 95% CI 2.1–4.5). These
associations become somewhat weaker but
remain statistically significant when con-
trols are introduced for co-occurring
anxiety, mood and substance use disorders.
Within-country patterns are again similar
to those in the combined sample, with
82% of within-country odds ratios greater
than 1.0 and 46% significant at the
P50.05 level (further details available
from the authors). The Netherlands is the
only country where reported disability
was consistently and significantly lower
than the results in the combined sample.
Only a handful of other within-country
odds ratios differed significantly from the
cross-national averages.
Twelve-month treatment
Patterns of treatment for emotional or sub-
stance use problems in the 12 months
before interview among respondents with
adult ADHD differed much more markedly
across surveys than did any of the other
statistics examined in this report (Table 7).
The highest proportion of cases receiving
treatment was in the USA, where nearly
half (49.7%) of respondents reported some
type of care, followed by roughly half as
many (19.9–23.8%) receiving treatment in
three of the European countries (Belgium,
The Netherlands and Spain), roughly half
this proportion (9.4–12.4%) in four other
countries (Colombia, France, Germany
and Mexico) and only 1.1% in Lebanon.
The majority of people receiving treatment
were seen in the specialty mental health
sector in all countries other than France
and Italy, where the majority were seen in
the general medical sector. It is important
to recognise that these patients were
generally seen not for problems with
attention, concentration, impulsivity or
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Table 4 Bivariate lifetime co-occurrence of multiply imputed adult attention-deficit hyperactivity disorder
and other DSM^IVdisorders (n¼11422)
Conditional prevalence estimates, % (s.e.) OR (95% CI)3
ADHD/Co1 Co/ADHD2
Classes of co-occurring disorders
Mood 11.1 (1.2) 24.8 (2.6) 3.9 (3.0^5.1)
Anxiety 9.9 (1.0) 38.1 (3.1) 4.0 (3.0^5.2)
Substance use 12.5 (2.3) 11.1 (2.0) 4.0 (2.8^5.8)
Number of co-occurring disorders
Exactly one 5.4 (0.7) 20.4 (2.1) 1.6 (1.3^2.1)
Exactly two 10.3 (1.5) 12.9 (1.6) 3.2 (2.4^4.2)
Three ormore 20.3 (2.4) 16.2 (2.4) 7.2 (5.1^10.2)
Any 8.5 (0.8) 49.5 (3.6) 3.9 (3.0^5.2)
ADHD, attention-deficit hyperactivity disorder; Co, comorbid disorder.
1. Conditional prevalence estimates of adult ADHD in the subsamples of respondents with the comorbid disorders.
2. Conditional prevalence estimates of the comorbid disorders in the subsample of respondents with adult ADHD.
3. All odds ratios significant at P50.05, two-sided test.
Table 5 Temporal priorities in first onset of co-occurring adult attention-deficit hyperactivity disorder and
other DSM^IVdisorders
Co-occurring disorder ADHD first
% (s.e.)
Other disorder
first
% (s.e.)
Both in
same year
% (s.e.)
n1
Mood disorder 85.6 (2.5) 9.5 (2.4) 4.9 (1.3) 310
Anxiety disorder 49.6 (3.9) 41.2 (4.0) 9.2 (2.0) 312
Specific phobia 34.3 (5.3) 54.8 (5.1) 11.0 (2.8) 185
Any other anxiety disorder 68.5 (4.1) 19.7 (3.2) 11.8 (2.2) 244
Substance use disorder 99.0 (0.7) 0.5 (0.5) 0.4 (0.4) 145
ADHD, attention-deficit hyperactivity disorder.
1. Number of respondents with co-occurrence of adult ADHD and the type of disorder specified.
Table 6 Disability in 30-day functioning associatedwith adult attention-deficit hyperactivity disorder
(n¼11422)
Disability % (s.e.) With controls for
socio-demographic
data1
OR (95% CI)
With controls for
socio-demographic data
and other DSM^IV
disorders2
OR (95% CI)
Self-care 4.2 (1.0) 1.5 (0.8^2.8) 0.9 (0.5^1.6)
Mobility 16.9 (1.9) 2.2* (1.6^2.9) 1.5* (1.1^2.0)
Cognitive 20.5 (2.6) 3.9* (2.8^5.4) 2.2* (1.5^3.3)
Days out of role 31.4 (3.0) 2.6* (2.0^3.5) 1.8* (1.3^2.5)
Social interaction 10.7 (1.7) 3.1* (2.1^4.5) 1.5* (1.0^2.2)
1. Based on logistic regression equations controlling for country, age, education, employment, marital status and
income.
2. Based on logistic regression equations controlling for country, age, education, employment, marital status, income,
anymood disorder, any anxiety disorder and any substance use disorder.
*P50.05 level, two-sided test.
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hyperactivity, but rather for other
emotional or behavioural problems.
DISCUSSION
Our findings have to be interpreted in the
context of several important limitations.
First, the diagnoses of adult ADHD in both
the DIS and clinical reappraisal interviews
were based on adult self-reports. Childhood
ADHD is diagnosed on the basis of parent
and teacher reports because children with
ADHD often are unaware of their symptoms
(Jensen et al, 1999). Use of informants, such
as spouses or work supervisors, to assess
adult ADHD is much more difficult
(although ideal in clinical settings), making
it necessary to base assessment largely on
self-report (Wender et al, 2001). Although
the one study that compared adult self-reports
with informant reports of ADHD symptoms
in a non-clinical sample found fairly strong
associations between the two reports
(Murphy & Schachar, 2000), our use of self-
report without confirmation by informant
reports still has to be seen as a limitation.
More importantly, our use of imputa-
tion to estimate adult ADHD introduced
several other important limitations that
need to be recognised in interpreting our
results. For one, the model relied on retro-
spective assessments of childhood symp-
toms in conjunction with only a single
question about recent adult persistence.
Even though these responses were strongly
related to independent clinical assessments
of adult ADHD in the US sample, the
coarse classification created by relying on
only a single question about recency limited
the texture with which we could study
correlates of adult ADHD. This coarseness
reduces the precision of estimates and, with
it, attenuates measures of association. In
addition, the imputation model was based
on a clinical calibration conducted only in
the USA. We have no way of confirming
the analytical assumption that the positive
and negative predictive values estimated
to calibrate the imputations are the same
in the other countries studied – an assump-
tion that is fundamental to the imputation
method. This is especially problematic
given that, as noted in the introduction,
little research on adult ADHD has been
conducted outside the USA, making it
unclear if the same markers apply in other
countries. Given the centrality of this issue,
it is important that the CIDI assessment of
adult ADHD is expanded for use in future
CIDI surveys (an expansion that has, in
fact, been implemented in the second flight
of WMH surveys that are currently taking
place) and that the validity of these
diagnoses is assessed with clinician-
administered diagnostic interviews in
clinical reappraisal studies embedded within
future surveys in countries other than the
USA. Another limitation of the imputation
model – which would be relevant even if
the model were equally accurate in all coun-
tries – is that it understates the strength of
associations of adult ADHD with covariates
that, owing to limitations of sample size,
were not included as predictors in the model.
This means that the evidence regarding so-
cio-demographic correlates of adult ADHD
reported here is likely to be conservative.
Finally, a question can be raised about
the validity of the DSM–IV ADHD criteria
when applied to adults, considering they
were developed with children in mind. Clin-
ical studies make it clear that symptoms of
ADHD are more heterogeneous and subtle
in adults than in children (De Quiros &
Kinsbourne, 2001), leading some clinical
researchers to suggest that assessment of adult
ADHD might require an increase in the vari-
ety of symptoms assessed (Barkley, 1995), a
reduction in the severity threshold (Ratey et
al, 1992) or a reduction in the DSM–IV ‘six
of nine’ symptom requirement (Kooij et al,
2005). To the extent that such considerations
in the criteria would lead to a more valid
assessment than in the current study, our
prevalence estimate is conservative.
Within the context of these limitations,
the results reported suggest that adult
ADHD as currently defined in the DSM–
IV is a commonly occurring and often
seriously impairing disorder. The 3.4%
estimated prevalence is likely to be conser-
vative for the reasons described above.
Although we would expect to find some
variation in prevalence from one country
to another, the amount of cross-national
variation in the estimated prevalence is
small compared with estimates for other
disorders (Demyttenaere et al, 2004). This
low variation might be due to method-
ological factors such as a general lack of
awareness about ADHD that makes it
difficult for respondents to discriminate
between questions, or that leads to normative
cultural interpretations of certain symptoms
(e.g. a high tolerance of hyperactivity in
boys). Another possibility, though, is that
adult ADHD is less strongly related than
other disorders to environmental determi-
nants that can vary across countries.
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Table 7 Twelve-month treatment among respondents with multiply imputed adult attention-deficit hyperactivity disorder
General medical
% (s.e.)
Anymental
health
% (s.e.)
Human
services
% (s.e.)
CAM
% (s.e.)
Any
professional
% (s.e.)
Any for ADHD
% (s.e.)
Belgium 10.4 (10.5) 13.8 (7.8) 0.0 0.0 21.5 (11.1) 0.0
Colombia 1.8 (1.0) 7.0 (4.1) 0.6 (0.6) 1.0 (1.1) 9.4 (4.4) 0.0
France 7.4 (2.7) 5.6 (3.3) 0.0 0.0 9.6 (3.6) 0.0
Germany 0.0 6.9 (5.8) 2.7 (2.8) 0.0 9.7 (6.0) 0.0
Italy 10.6 (4.2) 4.4 (2.8) 0.0 1.3 (1.3) 11.9 (4.4) 0.0
Lebanon 0.3 (1.5) 0.8 (0.9) 0.0 0.0 1.1 (1.7) 0.0
Mexico 2.9 (1.9) 8.2 (4.9) 0.0 2.1 (1.4) 12.4 (5.1) 1.9 (1.9)
Netherlands 18.6 (9.1) 18.8 (10.5) 2.2 (2.2) 12.3 (8.6) 23.8 (10.7) 1.9 (1.7)
Spain 10.2 (5.6) 13.9 (6.9) 0.0 0.0 19.9 (8.9) 3.2 (3.4)
USA 27.9 (4.3) 28.6 (3.8) 12.5 (2.5) 9.3 (2.3) 49.7 (4.1) 13.2 (2.9)
ADHD, attention-deficit hyperactivity disorder; CAM, complementary and alternativemedicine.
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The findings that adult ADHD is signif-
icantly more prevalent among men than
women and among people with low rather
than high educational levels are consistent
with much previous research (Scahill &
Schwab-Stone, 2000) and, as noted above
in the discussion of limitations, are likely
to be underestimates of the strength of these
associations owing to the attenuation intro-
duced by the coarseness of the imputations.
The failure to find an elevated prevalence
of ADHD among unemployed people,
however, is inconsistent with these same
studies. Nonetheless, we do find that
WMH respondents estimated to have
ADHD report significantly more disability
in role functioning, as indicated by more
days out of role and more disability in
social role functioning, than comparable
respondents without ADHD. These results
regarding role disability are consistent with
much previous research on disability in
adult ADHD (Able et al, 2007). It is note-
worthy that the WHO–DAS dimension as-
sociated with the highest impairment in
the current study is the cognitive disability
dimension. This finding is as one would ex-
pect, given the nature of the disorder. How-
ever, the WHO–DAS might underrepresent
ADHD disability because some WHO–DAS
dimensions tap areas where ADHD is not
highly disabling (e.g. people with ADHD
are often very mobile and overwork) and
because the WHO–DAS does not assess
many dimensions where people with
ADHD are thought to function less ade-
quately (e.g. poor sleep and nutrition, high
rates of accidents, high levels of smoking).
Moreover, people with ADHD often have
poor insight into their functioning, possibly
leading to underestimation of WHO–DAS
scores. It might also be that the social and
interpersonal disabilities associated with
adult ADHD require more detailed probing
to detect than provided in the WHO–DAS.
Based on these considerations, along with
the more general problem noted above that
imputation leads to attenuation of associa-
tions, the disabilities due to ADHD are
likely to be underestimated. This makes it
all the more striking that adult ADHD is
consistently associated across countries
with substantial elevations in disability that
cannot be accounted for by co-occurring
disorders.
The estimate that adult ADHD often
co-occurs with other DSM–IV disorders is
consistent with clinical evidence (Bieder-
man, 2004). Methodological analysis shows
that the evidence of co-occurrence holds
up when careful diagnoses are made aimed
at adjusting for overlap of symptoms, im-
precision of diagnostic criteria, or other
methodological confounds (Angold et al,
1999). The results regarding co-occurrence
in our report, however, are likely to be
much less precise – both because diagnoses
of co-occurring disorders are based on
a fully structured interview that, due to
its limited ability to make differential
diagnoses, will cause overestimation of co-
occurrence, and because the diagnoses of
adult ADHD are based on coarse imputa-
tions that, due to their individual-level
imprecision, will lead to attenuation of
correlations with other variables and
consequent underestimation of systematic
co-occurrence (i.e. underestimation of odds
ratios).
As one might expect from the early
onset of ADHD, comparison of reports of
age at onset showed that the estimated co-
occurrence in the WMH surveys is due to
temporally primary ADHD being related
to the subsequent onset of other disorders.
The main exception here is co-occurring
specific phobia, which is typically temp-
orally primary to ADHD. This last obser-
vation raises the question whether early
successful treatment of childhood ADHD
would influence secondary adult disorders,
an issue that is beyond the scope of the
current report to investigate. A related
question is whether adult treatment of
ADHD would have any effect on severity
or persistence of co-occurring temporally
secondary disorders. Long-term research is
needed to answer these questions. The
results reported here highlight the import-
ance of such long-term research by docu-
menting that adult ADHD is a relatively
common disorder in a number of countries,
often co-occurs with largely temporally
secondary conditions, and that it is asso-
ciated with substantial impairment in adult
role functioning.
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